Optimization of Dose Distributions for Adjuvant Locoregional Radiotherapy of Gastric Cancer by IMRT
Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by s...
Saved in:
Published in | Strahlentherapie und Onkologie Vol. 179; no. 8; pp. 557 - 563 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
München
Springer
01.08.2003
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
ISSN | 0179-7158 1439-099X |
DOI | 10.1007/s00066-003-1087-z |
Cover
Abstract | Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied.
For a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume.
When using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1).
IMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies. |
---|---|
AbstractList | Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied.BACKGROUND AND PURPOSELocoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied.For a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume.PATIENT AND METHODSFor a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume.When using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1).RESULTSWhen using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1).IMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies.CONCLUSIONIMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies. Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied. For a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume. When using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1). IMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies. Background and Purpose: Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of adjuvant radiochemotherapy, albeit with significant toxicity. The potential of intensity-modulated radiotherapy (IMRT) to reduce toxicity by significantly reducing maximum and median doses to organs at risk while still applying sufficient dose to the target volume in the upper abdomen was studied. Patient and Methods: For a typical configuration of target volumes and organs, a step-and-shoot IMRT plan (eight beam orientations), developed as a class solution for treatment of tumors in the upper abdomen (Figures 1 to 3), a conventional plan, a combination of the conventional plan with a kidney-sparing boost plan, and a conventional plan with noncoplanar ap and pa fields for improved kidney sparing were compared with respect to coverage of target volume and dose to organs at risk with a dose of 45 Gy delivered as the median dose to the target volume. Results: When using the conventional three-dimensionally planned box techniques, the right kidney could be kept below tolerance, but median dose to the left kidney amounted to between 14.8 and 26.9 Gy, depending on the plan. IMRT reduced the median dose to the left kidney to 10.5 Gy, while still keeping the dose to the right kidney < 8 Gy. Liver was spared better with IMRT. Dose to the lungs was not significantly different, and dose to the spinal cord was higher (but well below tolerance) with IMRT. The dose distribution within the target volume was less homogeneous than for the conventional plans. With regard to target coverage, > 90% of prescription dose were delivered to > 90% of target volume with IMRT (Table 1). Conclusion: IMRT has the potential to deliver efficient doses to target volumes in the upper abdomen, while delivering dose to organs at risk in a more advantageous fashion than a conventional technique. For clinical implementation, the possibility of extensive organ motion in the upper abdomen has to be taken into account for treatment planning and patient positioning. The multitude of potential risks related to its application has to be the subject of thorough follow-up and further studies.[PUBLICATION ABSTRACT] |
Author | Dobler, Barbara Mai, Sabine Hermann, Brigitte Wieland, Petra Wenz, Frederik Lohr, Frank Steil, Volker Tiefenbacher, Uta |
Author_xml | – sequence: 1 givenname: Frank surname: Lohr fullname: Lohr, Frank – sequence: 2 givenname: Barbara surname: Dobler fullname: Dobler, Barbara – sequence: 3 givenname: Sabine surname: Mai fullname: Mai, Sabine – sequence: 4 givenname: Brigitte surname: Hermann fullname: Hermann, Brigitte – sequence: 5 givenname: Uta surname: Tiefenbacher fullname: Tiefenbacher, Uta – sequence: 6 givenname: Petra surname: Wieland fullname: Wieland, Petra – sequence: 7 givenname: Volker surname: Steil fullname: Steil, Volker – sequence: 8 givenname: Frederik surname: Wenz fullname: Wenz, Frederik |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14991570$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/14509955$$D View this record in MEDLINE/PubMed |
BookMark | eNp90UFLHDEYBuBQLLpqf0AvEoT2NvXLzGQyOcpqrbAiiEJv4ZtM0maZnazJTGH315vprrR48BRInjfhy3tMDnrfG0I-M_jGAMRFBICqygCKjEEtsu0HMmNlITOQ8ucBmQETMhOM10fkOMYlAKtKWR6SI1byRDifEX2_HtzKbXFwvqfe0isfDb1ycQiuGafNSK0P9LJdjn-wH-jCax_Mr3SAHX3A1vnhtwm43kzhG5xyms6x1ybQZkNv7x4eT8lHi100n_brCXn6fv04_5Et7m9u55eLTBcs32asYmVTWy7bvDLcaG1RYAlcFzkXhtXcQo0WSqjbtmilyXVVacPzRqM2gtfFCfm6u3cd_PNo4qBWLmrTddgbP0YluADBC5Hg-Ru49GNIA0VV5zmvGBN5Qmd7NDYr06p1cCsMG_X6dwl82QOMGjsb0tAu_uekZOnF5NjO6eBjDMb-I6CmHtWuR5V6VFOPapsy4k1Gu-FvR0NA172TfAGlEKHL |
CODEN | STONE4 |
CitedBy_id | crossref_primary_10_1016_j_prro_2012_03_007 crossref_primary_10_1016_j_ijrobp_2007_09_055 crossref_primary_10_1186_1748_717X_7_192 crossref_primary_10_1016_j_currproblcancer_2011_03_001 crossref_primary_10_1586_14737140_2015_1042863 crossref_primary_10_1016_j_ijrobp_2008_04_033 crossref_primary_10_1016_j_ijrobp_2004_01_001 crossref_primary_10_1016_j_ijrobp_2006_01_001 crossref_primary_10_1007_s13566_019_00374_2 crossref_primary_10_1586_14737140_7_10_1379 crossref_primary_10_1016_j_ijrobp_2008_12_036 crossref_primary_10_1016_j_meddos_2006_03_001 crossref_primary_10_1177_030089160609200107 crossref_primary_10_1259_bjr_43441736 crossref_primary_10_1016_j_ijrobp_2005_03_013 crossref_primary_10_7314_APJCP_2014_15_17_7401 crossref_primary_10_1016_j_ijrobp_2004_02_051 crossref_primary_10_1016_j_meddos_2014_04_001 crossref_primary_10_1016_j_ijrobp_2009_06_058 crossref_primary_10_1186_1471_2407_12_287 crossref_primary_10_1016_j_radonc_2004_01_001 crossref_primary_10_1007_s00066_014_0787_x crossref_primary_10_1016_j_radonc_2006_08_013 crossref_primary_10_1007_s00066_013_0309_2 crossref_primary_10_1007_s00066_012_0254_5 crossref_primary_10_1016_j_ejso_2006_12_012 crossref_primary_10_1007_s11596_013_1193_9 crossref_primary_10_1007_s11912_008_0032_9 crossref_primary_10_3748_wjg_v12_i10_1511 crossref_primary_10_1007_s00520_013_1996_z crossref_primary_10_1007_s13566_015_0183_x crossref_primary_10_1186_s13014_018_1032_z crossref_primary_10_2349_biij_6_3_e29 |
ContentType | Journal Article |
Copyright | 2004 INIST-CNRS Urban & Vogel München 2003 |
Copyright_xml | – notice: 2004 INIST-CNRS – notice: Urban & Vogel München 2003 |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8C1 8FE 8FG 8FI 8FJ 8FK ABUWG AFKRA ARAPS BENPR BGLVJ CCPQU DWQXO FYUFA GHDGH HCIFZ K9. KB0 M0S M1P NAPCQ P5Z P62 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 |
DOI | 10.1007/s00066-003-1087-z |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database (NC LIVE) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Technology Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest Central Technology Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Technology Collection ProQuest One Academic Middle East (New) ProQuest Advanced Technologies & Aerospace Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central ProQuest One Applied & Life Sciences Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Public Health ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Advanced Technologies & Aerospace Database Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Technology Collection |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1439-099X |
EndPage | 563 |
ExternalDocumentID | 2230913841 14509955 14991570 10_1007_s00066_003_1087_z |
Genre | Journal Article Comparative Study Case Reports Report Case Study |
GroupedDBID | --- -Y2 -~C .86 .VR 04C 06C 06D 0R~ 0VY 123 1N0 1SB 203 29Q 29~ 2J2 2JN 2JY 2KG 2LR 2P1 2VQ 2~H 30V 3O- 4.4 406 408 409 40D 40E 53G 5RE 5VS 67Z 6NX 7RV 7X7 88E 8AO 8C1 8FE 8FG 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYXX AAYZH ABAKF ABBBX ABBRH ABBXA ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABKTR ABLJU ABMNI ABMQK ABNWP ABPLI ABQBU ABQSL ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSTC ACZOJ ADBBV ADHHG ADHIR ADHKG ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFHIU AFKRA AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHMBA AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARAPS ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AZFZN B-. BA0 BDATZ BENPR BGLVJ BGNMA BKEYQ BMSDO BPHCQ BSONS BVXVI CAG CCPQU CITATION COF CS3 CSCUP DARCH DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIHBH EIOEI EJD EMB EMOBN EN4 ESBYG EX3 FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GXS H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HQYDN HRMNR HVGLF HZ~ IHE IJ- IKXTQ IMOTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KPH LAS LLZTM M1P M4Y MA- N2Q N9A NAPCQ NB0 NPVJJ NQJWS NU0 O9- O93 O9I O9J OAM P62 P9S PF0 PHGZM PHGZT PQQKQ PROAC PSQYO PT4 Q2X QOR QOS R89 R9I RIG ROL RPX RRX RSV S16 S1Z S27 S37 S3B SAP SDH SHX SISQX SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 WOW X7J YLTOR Z45 ZMTXR ZOVNA ZXP ABRTQ IQODW PJZUB PPXIY PQGLB -5E -5G -BR -EM 3V. ADINQ CGR CUY CVF ECM EIF GQ6 NPM Z7U Z87 7XB 8FK DWQXO K9. PKEHL PQEST PQUKI 7X8 PUEGO |
ID | FETCH-LOGICAL-c312z-1614b8f59d26e5eccfa7a405c3257e185f08af0408dd3d9e2c66ce52bcace7583 |
IEDL.DBID | 7X7 |
ISSN | 0179-7158 |
IngestDate | Thu Sep 04 22:01:31 EDT 2025 Sat Jul 26 02:19:35 EDT 2025 Wed Feb 19 01:49:53 EST 2025 Mon Jul 21 09:14:42 EDT 2025 Tue Jul 01 01:18:13 EDT 2025 Thu Apr 24 23:11:39 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Dose repartition Human Adjuvant radiochemotherapy IMRT Adjuvant treatment Malignant tumor Regional Premises Stomach cancer Optimization Intensity modulated radiotherapy Cancerology Digestive diseases Intensity-modulated radiotherapy Gastric cancer Gastric disease |
Language | English |
License | http://www.springer.com/tdm CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c312z-1614b8f59d26e5eccfa7a405c3257e185f08af0408dd3d9e2c66ce52bcace7583 |
Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Report-1 ObjectType-Feature-3 content type line 23 ObjectType-Article-4 |
OpenAccessLink | http://hdl.handle.net/11380/1172477 |
PMID | 14509955 |
PQID | 822561172 |
PQPubID | 54006 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_75707537 proquest_journals_822561172 pubmed_primary_14509955 pascalfrancis_primary_14991570 crossref_primary_10_1007_s00066_003_1087_z crossref_citationtrail_10_1007_s00066_003_1087_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2003-08-01 |
PublicationDateYYYYMMDD | 2003-08-01 |
PublicationDate_xml | – month: 08 year: 2003 text: 2003-08-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | München |
PublicationPlace_xml | – name: München – name: Germany – name: Heidelberg |
PublicationTitle | Strahlentherapie und Onkologie |
PublicationTitleAlternate | Strahlenther Onkol |
PublicationYear | 2003 |
Publisher | Springer Springer Nature B.V |
Publisher_xml | – name: Springer – name: Springer Nature B.V |
SSID | ssj0016494 |
Score | 1.8669126 |
Snippet | Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116 suggest effectiveness of... Background and Purpose: Locoregional relapse is a problem frequently encountered with advanced gastric cancer. Data from the randomized Intergroup trial 116... |
SourceID | proquest pubmed pascalfrancis crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 557 |
SubjectTerms | Adenocarcinoma - radiotherapy Adenocarcinoma - surgery Adult Algorithms Biological and medical sciences Diseases of the digestive system Dose-Response Relationship, Radiation Female Gastrectomy Gastroenterology. Liver. Pancreas. Abdomen Humans Imaging, Three-Dimensional Kidney - radiation effects Liver - radiation effects Lung - radiation effects Medical sciences Optimization Pancreas Posture Radiation Dosage Radiation therapy Radiotherapy Dosage Radiotherapy Planning, Computer-Assisted Radiotherapy, Adjuvant Radiotherapy, Conformal - adverse effects Radiotherapy, Conformal - methods Radiotherapy. Instrumental treatment. Physiotherapy. Reeducation. Rehabilitation, orthophony, crenotherapy. Diet therapy and various other treatments (general aspects) Risk Assessment Software Spinal Cord - radiation effects Stomach Neoplasms - radiotherapy Stomach Neoplasms - surgery Stomach. Duodenum. Small intestine. Colon. Rectum. Anus Time Factors Tumors |
Title | Optimization of Dose Distributions for Adjuvant Locoregional Radiotherapy of Gastric Cancer by IMRT |
URI | https://www.ncbi.nlm.nih.gov/pubmed/14509955 https://www.proquest.com/docview/822561172 https://www.proquest.com/docview/75707537 |
Volume | 179 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swED8NkBASmhgfI4MVP_CEFJGPOrafJigUhiigCqS-RY7tTKCt6Uj7QP96zo4bxsN48Ut8VuS78935zr8DOMwyKiNZxKEwTITdImWhTDOMUpROqUkTahwcw-Amu3zoXo3oyNfm1L6scnEmuoNaV8rekR-jIUNTj-b2x-RvaJtG2eSq76CxBCsOuQzFmY3aeAsDAdFAe-NfsJjyRVIzchiiaGvDpjAL1Wz-ziytT2SNO1Q2rS3-73s6G9TfgM_eeSQnDbe_wCcz3oTVgU-Pb4G6xQPgj39ZSaqSnFW1IWcWG9e3taoJOqnkRD_N0IOekuvKolj-cteBZCj1o3-P9WKJL6SlU6RnBeOZFC_k52B4vw0P_fP73mXouyiEKo2TeYguXbfgJRU6yQxFjpWSSXTTFDKCGTTXZcRlibrMtU61MInKMmVoUiipDEYT6Q4sj6ux2QXCCy54zDjtKm2B3QqhRGYR5QyeFDg9gGixibnyEOO208XvvAVHdvtuAUktMinL5wEctSSTBl_jo8mdd5x5o8C4LaYsCmBvwarc62Kdt5ITwEH7FZXIZkbk2FSzOmdIi3EbC-Brw99_VkaPSlD67cOV92DNFfm5wsB9WJ4-z8x3dFamRceJJI68F9uxf9GBldPzm7vhKxu-6VA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIgESQrxKQ6H1AS5IEUkcvw4IVbuUXbpbpGor9RYc20EgulmaXaHd_8R_ZJwX9EBvPcdjJZ4Zzzfx-BuAV5wzHek8DpUTKkxzKkJNOWYpxlLmaMJcTccwPeGjs_TTOTvfgt_dXRhfVtntifVGbUvj_5G_xUCGoR7D7fvFz9A3jfKHq10HjcYqjt36F2Zs1bvxENX7OkmOPswGo7BtKhAaGiebEBFOmsuCKZtwx_ADCi00ohaD7yUcRq8ikrpA05bWUqtcYjg3jiW50cYhuKY47y24nVLKvRPJQV9RgomHaqjE8atFzGR3iBrVnKUY28OmEAzdenMlDN5f6Ao1UjStNP6PdeuYd_QQHrRglRw21vUIttz8MdyZtsfxT8B8xg3nor3JScqCDMvKkaHn4m3baFUEQTE5tN9XiNiXZFJ61syv9e9Hcqrtt_b-19oLf9RezpCBN8RLkq_JeHo6ewpnN7LAO7A9L-duF4jMpZKxkCw11hPJ5coo7hnsHO5MODyAqFvEzLSU5r6zxo-sJ2Ou190ToHomVJFtAnjTiywaPo_rBu9f0cxfCcwTYyaiAPY6VWWt71dZb6kBHPRP0Wn9SYyeu3JVZQJlMU8UATxr9PvPzIjgFGPPr535AO6OZtNJNhmfHO_BvbrAsC5KfAHby8uVe4lAaZnv1-ZJ4MtN-8MfAnwjtg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LT9wwEB7RRUKVqqpvUlrwob1UisjLcXxAFWXZsoXdohVI3FLHdlCrslnIrqrdf9h_1bHjpOVQbpzjsRLPeOZzZvwNwLs0pSIQRehzzbifFDHzRZziKUWqmOo4otrSMYzG6dF58uWCXqzB7_YujCmrbH2iddSqkuYf-S4GMgz1GG53S1cVcdoffJxd-6aBlEm0tt00hOuyoPYs25i743Gsl7_wNFfvDfuo-vdRNDg8OzjyXcMBX8ZhtPIR_SRFVlKuolRT_LhSMIGIRuI7M42RrQwyUaLZZ0rFiutIpqnUNCqkkBqBd4zzPoB1hkEy6cH6p8Px6aRLaaQJb4jGcU1YSLM2xRpYRlOM_H5TJoabfnUrSD6aiRr1VTaNNv6PhG1EHDyBxw7Kkv3G9p7Cmp4-g42RS9Y_B_kV3dGVu-dJqpL0q1qTvmHqdU22aoKQmeyrHwvE83NyUhlOzUv7c5JMhPruboctjfBnYeQkOTBmekOKJRmOJmcv4Pxelvgl9KbVVG8CyYqMZyHLaCKVoZkruOSp4bfT6LdwuAdBu4i5dITnpu_Gz7yjarbrbuhRDU8qy1cefOhEZg3bx12Dt29p5q8EniJDygIPtlpV5c4z1Hlnxx7sdE9xS5s8jZjqalHnDGXxFMk8eNXo95-ZEd9xSl_fOfMObODeyE-G4-MteGirD23F4hvozW8W-i2iqHmx7eyTwLf73hJ_ALsbLq4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Optimization+of+dose+distributions+for+adjuvant+locoregional+radiotherapy+of+gastric+cancer+by+IMRT&rft.jtitle=Strahlentherapie+und+Onkologie&rft.au=Lohr%2C+Frank&rft.au=Dobler%2C+Barbara&rft.au=Mai%2C+Sabine&rft.au=Hermann%2C+Brigitte&rft.date=2003-08-01&rft.issn=0179-7158&rft.volume=179&rft.issue=8&rft.spage=557&rft_id=info:doi/10.1007%2Fs00066-003-1087-z&rft_id=info%3Apmid%2F14509955&rft.externalDocID=14509955 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0179-7158&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0179-7158&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0179-7158&client=summon |